Influencing factors and diagnostic value of lung cancer related cerebral hemorrhage
WAN Shaoheng1 LI Zhongyan2 JIAO Xin1 WANG Jiasi1
1. Department of Laboratory, Dazhou Central Hospital, Sichuan Province, Dazhou 635000, China;
2. Department of Respiratory, Dazhou Central Hospital, Sichuan Province, Dazhou 635000, China
Abstract:Objective To study the influencing factors of lung cancer related cerebral hemorrhage (LCRCH) and the diagnostic value of the main factors. Methods Clinical data of 307 patients with lung cancer hospitalized in Dazhou Central Hospital from March 2014 to April 2020 were retrospectively analyzed, including 56 patients with LCRCH in the experimental group and 251 patients with lung cancer in the control group. Single factor analysis and propensity score matching (PSM) were used to screen out the suspected influencing factors. Logistic regression was used to analyze the independent risk factors. Receiver operating characteristic (ROC) curve was drawn and the diagnostic indexes were calculated. Results The results of univariate analysis and PSM showed that platelets (PLT), prothrombin time (PT) and serum tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 125 and CA199 were significantly different between the test group and control group (P<0.05). There were no statistically significant differences in gender, age, lung cancer type, activated partial thrombin time (APTT), international standardized ratio (INR), and serum tumor marker neuron specific enolase (NSE), cyto-keratin 19 fragment antigen 21-1 (CyFRA21-1) between the two groups (P>0.05). Logistic regression analysis showed that CEA level was increased (β=0.001, OR=1.001, 95%CI=1.000-1.002), CA199 level was increased (β=0.004, OR=1.004, 95%CI=1.003-1.004) and PT was prolonged (β=0.157, OR=1.170, 95%CI=1.084-1.263) were independent risk factors for LCRCH (P<0.05). The area under ROC curve (AUC) of PT for LCRCH diagnosis was 0.82 (95%CI=0.74-0.89). Conclusion Prolonged PT and elevated CEA and CA199 levels are independent risk factors for LCRCH, and PT can be used as a good indicator for the diagnosis of this disease.
万绍恒; 李中燕; 焦鑫; 王家驷. 肺癌合并脑出血的影响因素及其诊断价值[J]. 中国当代医药, 2022, 29(20): 166-169.
WAN Shaoheng; LI Zhongyan; JIAO Xin; WANG Jiasi. Influencing factors and diagnostic value of lung cancer related cerebral hemorrhage. 中国当代医药, 2022, 29(20): 166-169.
Gon Y,Todo K,Mochizuki H,et al.Cancer is an independent predictor of poor outcomes in patients following intracerebral hemorrhage[J].Eur J Neurol,2018,25(1):128-134.
Adams HP Jr.Cancer and Cerebrovascular Disease[J].Curr Neurol Neurosci Rep,2019,19(10):73.
[4]
Cohen-Neamie ZJ,Ganti L,Stead TS,et al.Acute Headache Due to Intracerebral Hemorrhage Secondary to Brain Metastases[J].Cureus,2021,13(8):e16889.
[5]
Zhao Y,Xie H,Pan C,et al.Clinical Characteristics and Risk Factors of Cerebral Hemorrhage in Patients with Occult Malignant Tumors[J].Neuropsychiatr Dis Treat,2021,17:2729-2738.
Richter I,Jirasek T,Havlickova I,et al.The expression of PD-L1 in patients with castrate prostate cancer treated with enzalutamide[J].J BUON,2018,23(6):1796-1802.
[14]
Gusdon AM,Nyquist PA,Torres-Lopez VM,et al.Perihematomal Edema After Intracerebral Hemorrhage in Patients With Active Malignancy[J].Stroke,2020,51(1):129-136.
Qin K,Chen Y,Long H,et al.The biomarkers and potential pathogenesis of lung cancer related cerebral hemorrhage[J].Medicine(Baltimore),2019,98(20):e15693.
[17]
Navi BB,Reichman JS,Berlin D,et al.Intracerebral and subarachnoid hemorrhage in patients with cancer[J].Neurology,2010,74(6):494-501.
[18]
Xie X,Chen L,Zeng J,et al.Clinical features and biological markers of lung cancer-associated stroke[J].J Int Med Res,2016,44(6):1483-1491.
[19]
Shao B,Wahrenbrock MG,Yao L,et al.Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome[J].Blood,2011,118(15):4015-4023.